Clinical Management of Bladder Pain Syndrome/Interstitial Cystitis: A Review on Current Recommendations and Emerging Treatment Options

References

• Fall M, Baranowski AP, Fowler CJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):35–48. doi:10.1016/j.eururo.2009.08.02019733958
   PubMed Web of Science ®Google Scholar
• Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–544. doi:10.1016/j.juro.2011.03.13221683389
   PubMed Web of Science ®Google Scholar
• Suskind AM, Berry SH, Ewing BA, et al. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189(1):141–145. doi:10.1016/j.juro.2012.08.08823164386
   PubMed Web of Science ®Google Scholar
• Afari N, Buchwald D, Clauw D, et al. A MAPP network case-control study of urological chronic pelvic pain compared with nonurological pain conditions. Clin J Pain. 2020;36(1):8–15. doi:10.1097/AJP.000000000000076931794439
   PubMed Web of Science ®Google Scholar
• Malde S, Palmisani S, Al-Kaisy A, Sahai A. Guideline of guidelines: bladder pain syndrome. BJU Int. 2018;122(5):729–743. doi:10.1111/bju.1439929777618
   PubMed Web of Science ®Google Scholar
• Doggweiler R, Whitmore KE, Meijlink JM, et al. A standard terminology in chronic pelvic pain syndromes: a report from the chronic pelvic pain working group of the international continence society. Neurourol Urodyn. 2017;36(4):984–1008. doi:10.1002/nau.2307227564065
   PubMed Web of Science ®Google Scholar
• Crane A, Lloyd J, Shoskes DA. Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT. Can J Urol. 2018;25(2):9250–9254.29680002
   PubMed Web of Science ®Google Scholar
• Van de Merwe J, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–67. doi:10.1016/j.eururo.2007.09.01917900797
   PubMed Web of Science ®Google Scholar
• Yeh HL, Jhang JF, Kuo YC, Kuo HC. Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment. Neurourol Urodyn. 2019;38(7):1985–1993. doi:10.1002/nau.2410431310370
   PubMed Web of Science ®Google Scholar
• Propert KJ, Schaeffer AJ, Brensinger CM, Kusek JW, Nyberg LM, Landis JR. A prospective study of interstitial cystitis: results of longitudinal follow up of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. J Urol. 2000;163(5):1434–1439. doi:10.1016/S0022-5347(05)67637-910751852
   PubMed Web of Science ®Google Scholar
• Chaiken DC, Blaivas JG, Blaivas ST. Behavioural therapy for the treatment of refractory interstitial cysitits. J Urol. 1993;149(6):1445–1448. doi:10.1016/S0022-5347(17)36411-X8501784
   PubMed Web of Science ®Google Scholar
• Foster HE, Hanno PM, Nickel C, et al. Effect of Amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1853–1858. doi:10.1016/j.juro.2009.12.10620303115
   PubMed Web of Science ®Google Scholar
• Lukban J, Whitmore K, Kellogg-Spadt S, Bologna A, Lesher A, Fletcher E. The effect of manual physical therapy in patients diagnosed with interstitial cystitis, high tine pelvic floor dysfunction, and sacroiliac dysfunction. Urology. 2001;Jun;57(6 Suppl 1):121–122. doi:10.1016/S0090-4295(01)01074-3
   Google Scholar
• FitzGerald MP, Payne CK, Lukacz ES, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187(6):2113–2118. doi:10.1016/j.juro.2012.01.12322503015
   PubMed Web of Science ®Google Scholar
• Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome and comorbid conditions. BJU Int. 2012;109(11):1584–1591. doi:10.1111/j.1464-410X.2011.10860.x22233286
   PubMed Web of Science ®Google Scholar
• van Ophoven A, Pokupic S, Heinecke A, et al. A prospective, randomized, placebo controlled double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172:533–536. doi:10.1097/01.ju.0000132388.54703.4d15247722
   PubMed Web of Science ®Google Scholar
• Lee JW, Han DY, Jeong HJ. Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline and a nonsteroidal anti-inflammatory drug. Int Neurourol J. 2010;14:256–260. doi:10.5213/inj.2010.14.4.25621253338
   PubMedGoogle Scholar
• Hwang P, Auclair B, Beechinor D, et al. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis. Urology. 1997;50(1):39–43. doi:10.1016/S0090-4295(97)00110-69218016
   PubMed Web of Science ®Google Scholar
• Sairanen J, Tammela TLJ, Leppilahti M, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005;174(6):2235–2238. doi:10.1097/01.ju.0000181808.45786.8416280777
   PubMed Web of Science ®Google Scholar
• Nickel JC, Herschorn S, Whitmore KE, et al. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015;193(3):857–862. doi:10.1016/j.juro.2014.09.03625245489
   PubMed Web of Science ®Google Scholar
• Al-Zahrani AA, Gajewski JB. Long-term efficacy and tolerability of pentosan polysulphate sodium in the treatment of bladder pain syndrome. Can Urol Assoc J. 2011;5(2):113–118. doi:10.5489/cuaj.1009521470538
   PubMed Web of Science ®Google Scholar
• Jepsen JV, Sall M, Rhodes PR, Schmidt D, Messing E, Bruskewitz RC. Long-term experience with pentosanpolysulfate in interstitial cystitis. Urology. 1998;51(3):381–387. doi:10.1016/S0090-4295(97)00714-09510339
   PubMed Web of Science ®Google Scholar
• Pearce WA, Chen R, Jain N. Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium. Ophthalmology. 2018;125(11):1793–1802. doi:10.1016/j.ophtha.2018.04.02629801663
   PubMed Web of Science ®Google Scholar
• Jain N, Li AL, Yu Y, Van der Beek BL. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. Br J Ophthalmol. 2020;104(8):1093–1097.31694837
   PubMed Web of Science ®Google Scholar
• Van Ophoven A, Heinecke A, Hertle L. Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis. Urology. 2005;66(4):707–711. doi:10.1016/j.urology.2005.04.05616230121
   PubMed Web of Science ®Google Scholar
• Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87(3):207–212. doi:10.1046/j.1464-410x.2001.02031.x11167643
   PubMed Web of Science ®Google Scholar
• Sant GR, Propert KJ, Hanno PM, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170(3):810–815. doi:10.1097/01.ju.0000083020.06212.3d12913705
   PubMed Web of Science ®Google Scholar
• Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012;188(4):1186–1191. doi:10.1016/j.juro.2012.06.02322901569
   PubMed Web of Science ®Google Scholar
• Rawls WF, Cox L, Rovner ES. Dimethyl Sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: a review. Neurourol Urodyn. 2017;36(7):1677–1684. doi:10.1002/nau.2320428220525
   PubMed Web of Science ®Google Scholar
• Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988;140(1):36–39. doi:10.1016/S0022-5347(17)41478-93288775
   PubMed Web of Science ®Google Scholar
• Lim Y, Dwyer P, Murray CJ, et al. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2017;28(7):1085–1089. doi:10.1007/s00192-016-3232-027987022
   PubMed Web of Science ®Google Scholar
• Tutolo M, Ammirati E, Castagna G, et al. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroitin sulphate 2% for painful bladder syndrome/interstitial cystitis. Int Braz J Urol. 2017;43(1):124–141. doi:10.1590/s1677-5538.ibju.2016.0302
   Web of Science ®Google Scholar
• NICE. Interstitial cystitis: dimethyl sulfoxide bladder instillation. Evidence summary [ESUOM26]. 2 20, 2014.
   Google Scholar
• Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology. 2005;65(1):45–48. doi:10.1016/j.urology.2004.08.05615667861
   PubMed Web of Science ®Google Scholar
• Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. J Formos Med Assoc. 2001;100(5):309–314.11432309
   PubMed Web of Science ®Google Scholar
• Parsons CL, Zupkas P, Proctor J, et al. Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis. J Sex Med. 2012;9(1):207–212. doi:10.1111/j.1743-6109.2011.02542.x22082303
   PubMed Web of Science ®Google Scholar
• Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pflüger H. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(5):717–721. doi:10.1007/s00192-007-0515-518097627
   PubMed Web of Science ®Google Scholar
• Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pflüger H. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol. 2005;47(3):393–397. doi:10.1016/j.eururo.2004.10.02215716206
   PubMed Web of Science ®Google Scholar
• Gülpınar Ö, Esen B, Kayış A, Gökçe Mİ, Süer E. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2018;37(1):257–262. doi:10.1002/nau.2328428480984
   PubMed Web of Science ®Google Scholar
• Chintea CL, Belal M. Is there enough evidence for the use of intravesical instillations of glycosaminoglycan analogues in interstitial cystitis? BJU Int. 2013;111(2):192–193. doi:10.1111/j.1464-410X.2012.11635.x23356746
   PubMed Web of Science ®Google Scholar
• Nickel JC, Egerdie B, Downey J, et al. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int. 2009;103(1):56–60. doi:10.1111/j.1464-410X.2008.08028.x18778342
   PubMed Web of Science ®Google Scholar
• Nickel JC, Egerdie RB, Steinhoff G, Palmer B, Hanno P. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome. Urology. 2010;76(4):804–809. doi:10.1016/j.urology.2010.03.01620494413
   PubMed Web of Science ®Google Scholar
• Cervigni M, Natale F, Nasta L, Mako A. Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results. Int Urogynecol J. 2012;23(9):1187–1192. doi:10.1007/s00192-012-1742-y22569687
   PubMed Web of Science ®Google Scholar
• Cervigni M, Sommariva M, Tenaglia R, et al. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2017;36(4):1178–1186. doi:10.1002/nau.2309127654012
   PubMed Web of Science ®Google Scholar
• Arslan B, Gönültaş S, Gökmen E, Özman O, Avci MA, Özdemir E. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome. Int Urogynecol J. 2019;30(11):1857–1862. doi:10.1007/s00192-019-04036-231254047
   PubMed Web of Science ®Google Scholar
• Pyo JS, Cho WJ. Systematic review and meta-analysis of intravesical hyaluronic acid and hyaluronic acid/chondroitin sulfate instillation for interstitial cystitis/painful bladder syndrome. Cell Physiol Biochem. 2016;39(4):1618–1625. doi:10.1159/00044786327627755
   PubMedGoogle Scholar
• Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol. 1997;79(2):168–171. doi:10.1046/j.1464-410X.1997.03384.x9052464
   PubMedGoogle Scholar
• Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol. 2008;179(1):177–185. doi:10.1016/j.juro.2007.08.17018001798
   PubMed Web of Science ®Google Scholar
• Barua JM, Arance I, Angulo JC, Riedl CR. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2016;27(8):1137–1147. doi:10.1007/s00192-015-2890-726590137
   PubMed Web of Science ®Google Scholar
• Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103(7):910–918. doi:10.1111/j.1464-410X.2008.08162.x19021619
   PubMed Web of Science ®Google Scholar
• International Painful Bladder Foundation. Interstitial cystitis/painful bladder syndrome: anesthetic intravesical cocktails. Available from: https://www.painful-bladder.org/pdf/IPBF.intravesicalcocktails.pdf. Accessed 7, 2020.
   Google Scholar
• Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology. 2008;71(1):67–70. doi:10.1016/j.urology.2007.09.06718242367
   PubMed Web of Science ®Google Scholar
• Cocci A, Alowidah I, Skews R, Hashim H. 421 Comparison of Cystistat®, iAluril®, and Whitmore Cocktail for treatment of patients with bladder pain syndrome/interstitial cystitis. Eur Urol Suppl. 2016;15(3):e421. doi:10.1016/S1569-9056(16)60423-2
   Google Scholar
• Cox A, Golda N, Nadeau G, et al. CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10(5–6):E136–E155. doi:10.5489/cuaj.378627790294
   PubMed Web of Science ®Google Scholar
• Olsen LE, Dyer JE, Haq A, Ockrim J, Greenwell TJ. A systematic review on the literature on cystodistention in bladder pain syndrome. Int Urogynaecol J. 2018;29(2):251–257. doi:10.1007/s00192-017-3355-y
   Web of Science ®Google Scholar
• Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494–499. doi:10.1016/j.urology.2005.04.01116140064
   PubMed Web of Science ®Google Scholar
• Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(5):290–295. doi:10.1007/s00192007001911052564
   PubMed Web of Science ®Google Scholar
• Ryu J, Pak S, Song M, Chun JY, Hong S, Choo MS. Elimination of hunner’s ulcers by fulguration in patients with interstitial cystitis: is it effective and long lasting? Korean J Urol. 2013;54(11):767–771. doi:10.4111/kju.2013.54.11.76724255759
   PubMedGoogle Scholar
• Ko KJ, Cho WJ, Lee YS, Choi J, Byun HJ, Lee KS. Comparison of the efficacy between transurethral coagulation and transurethral resection of hunner lesion in interstitial cystitis/bladder pain syndrome patients: a prospective randomized controlled trial. Eur Urol. 2020;77(5):644–651. doi:10.1016/j.eururo.2020.01.00231959549
   PubMed Web of Science ®Google Scholar
• Rofiem O, Hom D, Fried RM, et al. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol Assoc J. 2009;3(6):473–477.
   Google Scholar
• Cox M, Klutke JJ, Klutke CG. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of hunner’s ulcer subtype interstitial cystitis. Can J Urol. 2009;16(2):4536–4540.19364425
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhou X, Chen Z, et al. Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome. BMC Urol. 2020;20(1):36. doi:10.1186/s12894-020-00597-332228552
   PubMed Web of Science ®Google Scholar
• Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin A type injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int. 2009;104(5):657–661. doi:10.1111/j.1464-410X.2009.08495.x19338543
   PubMed Web of Science ®Google Scholar
• Akiyama Y, Nomiya A, Niimi A, et al. Botulinum toxin type A injection for refractory interstitial cystitis: a randomized comparative study and predictors of treatment response. Int J Urol. 2015;22(9):835–841. doi:10.1111/iju.1283326041274
   PubMed Web of Science ®Google Scholar
• Kuo HC, Jiang YH, Tsai YC, Kuo YC. Intravesical botulinum toxin-a injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment – a prospective, multicener, randomized, double blind, placebo controlled clinical trial. Neurourol Urodyn. 2016;35(5):609–614. doi:10.1002/nau.2276025914337
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Q, Wu Q, Chen Y, Wu P. Intravesical botulinum toxin A injections for bladder pain syndrome/interstitial cystitis: a systematic review and meta-analysis of controlled studies. Med Sci Monit. 2016;14(22):3257–3267. doi:10.12659/MSM.897350
   Web of Science ®Google Scholar
• Evans RJ, Overholt T, Colaco M, Walker SJ. Injection location does not impact botulinum toxin A efficacy in interstitial cystitis/bladder pain syndrome patients. Can J Urol. 2020;27(1):10125–10129.32065870
   PubMed Web of Science ®Google Scholar
• Lee C-L, Kuo H-C. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician. 2013;16(2):109–116.23511677
   PubMed Web of Science ®Google Scholar
• Pinto R, Lopes T, Costa D, et al. Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A. Urology. 2014;83(5):1030–1034. doi:10.1016/j.urology.2014.01.01824767520
   PubMed Web of Science ®Google Scholar
• Gajewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int. 2011;107(8):1258–1264. doi:10.1111/j.1464-410X.2010.09697.x20883483
   PubMed Web of Science ®Google Scholar
• Wang J, Chen Y, Chen J, Zhang G, Wu P. Sacral neuromodulation for refractory bladder pain syndrome/interstitial cystitis: a global systematic review and meta-analysis. Sci Rep. 2017;7(1):11031. doi:10.1038/s41598-017-11062-x28887515
   PubMed Web of Science ®Google Scholar
• Peters KM, Feber KM, Bennett RC. A prospective, single blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystits. BJU Int. 2007;100(4):835–839. doi:10.1111/j.1464-410X.2007.07082.x17822464
   PubMed Web of Science ®Google Scholar
• Valdemar A, Granlund P, Schultz A, Talseth T, Hedlund L, Frich L. Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol. 2012;46(4):284–289. doi:10.3109/00365599.2012.66978922452583
   PubMedGoogle Scholar
• Rossberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology. 2007;70(4):638–642. doi:10.1016/j.urology.2007.05.02817991529
   PubMed Web of Science ®Google Scholar
• Osman NI, Bratt DG, Downey AP, et al. A systematic review of surgical interventions for the treatment of bladder pain syndrome/Interstitial cystitis. Eur Urol Focus. 2020;S2405–4569(20)30071–7.
   Google Scholar
• Chen H, Wang F, Chen W, et al. Efficacy of daily low-dose sildenafil for treating interstitial cystitis: results of a randomized, double-blind, placebo-controlled trial—treatment of interstitial cystitis/painful bladder syndrome with low-dose sildenafil. Urology. 2014;84(1):51–56. doi:10.1016/j.urology.2014.02.05024837447
   PubMed Web of Science ®Google Scholar
• Bosch PC. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome. J Urol. 2014;191(1):77–82. doi:10.1016/j.juro.2013.06.03823792149
   PubMed Web of Science ®Google Scholar
• Qu H-C, Zhang W, Yan S, Liu Y-L, Wang P, Hurst R. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis. PLoS One. 2014;9(9):e106321. doi:10.1371/journal.pone.010632125181532
   PubMed Web of Science ®Google Scholar
• Wang ZY, Wang P, Bjorling DE. Treatment with a cannabinoid receptor 2 agonist decreases severity of established cystitis. J Urol. 2014;191(4):1153–1158. doi:10.1016/j.juro.2013.10.10224184363
   PubMed Web of Science ®Google Scholar
• Krenn H, Daha LK, Oczenski W, Fitzgerald RD. A case of cannabinoid rotation in a young woman with chronic cystitis. J Pain Symptom Manage. 2003;25(1):3–4. doi:10.1016/S0885-3924(02)00601-212565180
   PubMed Web of Science ®Google Scholar
• Peters KM, Hasenau D, Killinger KA, et al. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation. Int Urol Nephrol. 2014;46(12):2291–2295. doi:10.1007/s11255-014-0828-525209396
   PubMed Web of Science ®Google Scholar
• Rappaport YH, Zisman A, Jeshurun-Gutshtat M, et al. Safety and feasibility of intravesical instillation of botulinum toxin-A in hydrogel-based slow-release delivery system in patients with interstitial cystitis-bladder pain syndrome: a Pilot Study. Urology. 2018;114:60–65. doi:10.1016/j.urology.2017.12.02829307733
   PubMed Web of Science ®Google Scholar
• Nickel JC, Jain P, Shore N, et al. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med. 2012;4(143):143ra100. doi:10.1126/scitranslmed.3003804
   PubMed Web of Science ®Google Scholar
• Gallego-Vilar D, Garcia-Fadrique G, Povo-Martin I, et al. Maintenance of the response to dimethyl sulfoxide treatment using hyperbaric oxygen in interstitial cystitis/painful bladder syndrome: a prospective, randomized, comparative study. Urol Int. 2013;90:411–416. doi:10.1159/00034369723485788
   PubMed Web of Science ®Google Scholar
• Chuang Y-C, Meng E, Chancellor M, Kuo H-C. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis/bladder pain syndrome—a prospective, multicenter, randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2013;39(5):1505–1514. doi:10.1002/nau.24382
   Web of Science ®Google Scholar